We used a c-Myc-responsive luciferase reporter assay to study c-Myc pathway activation and found that FT671 significantly increased c-Myc transcriptional activity in H1299 lung cancer cells in a dose-dependent manner (Fig. 3C). Here, MYC is linked to lung carcinoma.